Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eccoxolac 300mg capsules
1001010E0BFAAAC
|
Eccoxolac | Etodolac | Musculoskeletal and Joint Diseases | No data available |
|
Econac 75mg/3ml solution for injection ampoules
1001010C0CFABAA
|
Econac | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Econac SR 75mg tablets
1001010C0CKAAAL
|
Econac | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Econac XL 100mg tablets
1001010C0CKABAF
|
Econac | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Edrophonium chloride 10mg/1ml inj ampoules
1002010H0AAAAAA
|
Edrophonium chloride | Edrophonium chloride | Musculoskeletal and Joint Diseases | No data available |
|
Edrophonium chloride 150mg/15ml solution for injection vials
1002010H0AAABAB
|
Edrophonium chloride | Edrophonium chloride | Musculoskeletal and Joint Diseases | No data available |
|
Ellimans Universal Muscle Rub lotion
1003020V0BDAAA0
|
Ellimans | Turpentine oil | Musculoskeletal and Joint Diseases | No data available |
|
Elstabya 120mg tablets
1001040V0BCABAB
|
Elstabya | Febuxostat | Musculoskeletal and Joint Diseases | No data available |
|
Elstabya 80mg tablets
1001040V0BCAAAA
|
Elstabya | Febuxostat | Musculoskeletal and Joint Diseases | No data available |
|
Emflex 60mg capsules
100101050BBAAAA
|
Emflex | Acemetacin | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel 25mg inj vials
1001030D0BBAAAA
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel 25mg/0.5ml inj pre-filled MyClic pens
1001030D0BBAHAG
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel 25mg/0.5ml solution for injection pre-filled syringes
1001030D0BBAEAD
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel 50mg inj vials
1001030D0BBABAB
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel 50mg/1ml solution for injection pre-filled syringes
1001030D0BBACAC
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel Paediatric 10mg inj vials
1001030D0BBAGAF
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enbrel Paediatric 25mg inj vials
1001030D0BBADAA
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Enlon 150mg/15ml solution for injection vials
1002010H0BDAAAB
|
Enlon | Edrophonium chloride | Musculoskeletal and Joint Diseases | No data available |
|
Enstar SR 75 tablets
1001010C0CMAAAL
|
Enstar | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Enstar XL 100 tablets
1001010C0CMABAF
|
Enstar | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Erelzi 25mg/0.5ml solution for injection pre-filled syringes
1001030D0BDAAAD
|
Erelzi | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Erelzi 50mg/1ml solution for injection pre-filled pens
1001030D0BDACAE
|
Erelzi | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Erelzi 50mg/1ml solution for injection pre-filled syringes
1001030D0BDABAC
|
Erelzi | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Etanercept 10mg inj vials
1001030D0AAAFAF
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Etanercept 25mg inj vials
1001030D0AAAAAA
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.